Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Immuneering (IMRX) Accumulated Expenses: 2020-2023

Historic Accumulated Expenses for Immuneering (IMRX) over the last 4 years, with Dec 2023 value amounting to $5.2 million.

  • Immuneering's Accumulated Expenses rose 39.22% to $4.6 million in Q3 2024 from the same period last year, while for Sep 2024 it was $4.6 million, marking a year-over-year increase of 39.22%. This contributed to the annual value of $5.2 million for FY2023, which is 14.95% up from last year.
  • Latest data reveals that Immuneering reported Accumulated Expenses of $5.2 million as of FY2023, which was up 14.95% from $4.5 million recorded in FY2022.
  • In the past 5 years, Immuneering's Accumulated Expenses ranged from a high of $5.2 million in FY2023 and a low of $698,992 during FY2020.
  • Moreover, its 3-year median value for Accumulated Expenses was $4.5 million (2022), whereas its average is $4.5 million.
  • Data for Immuneering's Accumulated Expenses shows a peak YoY soared of 467.31% (in 2021) over the last 5 years.
  • Immuneering's Accumulated Expenses (Yearly) stood at $698,992 in 2020, then skyrocketed by 467.31% to $4.0 million in 2021, then rose by 13.51% to $4.5 million in 2022, then climbed by 14.95% to $5.2 million in 2023.